226 related articles for article (PubMed ID: 23670031)
1. Traumatic intracranial hemorrhage in patients taking dabigatran: report of 3 cases and review of the literature.
Wassef SN; Abel TJ; Grossbach A; Viljoen SV; Jackson AW; Howard MA; Greenlee JD
Neurosurgery; 2013 Aug; 73(2):E368-73; discussion E373-4. PubMed ID: 23670031
[TBL] [Abstract][Full Text] [Related]
2. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
Berger R; Salhanick SD; Chase M; Ganetsky M
Ann Emerg Med; 2013 Apr; 61(4):475-9. PubMed ID: 23522810
[TBL] [Abstract][Full Text] [Related]
3. Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation.
Larsen TB; Gorst-Rasmussen A; Rasmussen LH; Skjøth F; Rosenzweig M; Lip GY
Am J Med; 2014 Jul; 127(7):650-656.e5. PubMed ID: 24530792
[TBL] [Abstract][Full Text] [Related]
4. Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.
Uchiyama S; Ibayashi S; Matsumoto M; Nagao T; Nagata K; Nakagawara J; Tanahashi N; Tanaka K; Toyoda K; Yasaka M
J Stroke Cerebrovasc Dis; 2012 Apr; 21(3):165-73. PubMed ID: 22440950
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
[TBL] [Abstract][Full Text] [Related]
6. Intracranial hemorrhage during dabigatran treatment.
Komori M; Yasaka M; Kokuba K; Matsuoka H; Fujimoto S; Yoshida M; Kameda K; Shono T; Nagata S; Ago T; Kitazono T; Okada Y
Circ J; 2014; 78(6):1335-41. PubMed ID: 24662438
[TBL] [Abstract][Full Text] [Related]
7. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.
Hart RG; Diener HC; Yang S; Connolly SJ; Wallentin L; Reilly PA; Ezekowitz MD; Yusuf S
Stroke; 2012 Jun; 43(6):1511-7. PubMed ID: 22492518
[TBL] [Abstract][Full Text] [Related]
8. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
9. Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran.
Vaughan Sarrazin MS; Jones M; Mazur A; Chrischilles E; Cram P
Am J Med; 2014 Dec; 127(12):1179-85. PubMed ID: 25107386
[TBL] [Abstract][Full Text] [Related]
10. Removal of dabigatran by hemodialysis.
Chang DN; Dager WE; Chin AI
Am J Kidney Dis; 2013 Mar; 61(3):487-9. PubMed ID: 23219111
[TBL] [Abstract][Full Text] [Related]
11. Dabigatran for stroke prevention in atrial fibrillation.
Hohnloser SH; Diener HC
Hamostaseologie; 2012; 32(3):216-20. PubMed ID: 22739760
[TBL] [Abstract][Full Text] [Related]
12. Dabigatran bleed risk with closed head injuries: are we prepared?
Parra MW; Zucker L; Johnson ES; Gullett D; Avila C; Wichner ZA; Kokaram CR
J Neurosurg; 2013 Sep; 119(3):760-5. PubMed ID: 23634730
[TBL] [Abstract][Full Text] [Related]
13. Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report.
Faust AC; Peterson EJ
J Emerg Med; 2014 Apr; 46(4):525-9. PubMed ID: 24508114
[TBL] [Abstract][Full Text] [Related]
14. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
Eikelboom JW; Wallentin L; Connolly SJ; Ezekowitz M; Healey JS; Oldgren J; Yang S; Alings M; Kaatz S; Hohnloser SH; Diener HC; Franzosi MG; Huber K; Reilly P; Varrone J; Yusuf S
Circulation; 2011 May; 123(21):2363-72. PubMed ID: 21576658
[TBL] [Abstract][Full Text] [Related]
15. Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation.
Chevalier J; Giroud M; de Pouvourville G
Cerebrovasc Dis; 2013; 35(4):320-6. PubMed ID: 23615428
[TBL] [Abstract][Full Text] [Related]
16. The importance of postapproval data for dabigatran.
Redberg RF
JAMA Intern Med; 2015 Jan; 175(1):25. PubMed ID: 25365377
[No Abstract] [Full Text] [Related]
17. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.
Connolly SJ; Wallentin L; Ezekowitz MD; Eikelboom J; Oldgren J; Reilly PA; Brueckmann M; Pogue J; Alings M; Amerena JV; Avezum A; Baumgartner I; Budaj AJ; Chen JH; Dans AL; Darius H; Di Pasquale G; Ferreira J; Flaker GC; Flather MD; Franzosi MG; Golitsyn SP; Halon DA; Heidbuchel H; Hohnloser SH; Huber K; Jansky P; Kamensky G; Keltai M; Kim SS; Lau CP; Le Heuzey JY; Lewis BS; Liu L; Nanas J; Omar R; Pais P; Pedersen KE; Piegas LS; Raev D; Smith PJ; Talajic M; Tan RS; Tanomsup S; Toivonen L; Vinereanu D; Xavier D; Zhu J; Wang SQ; Duffy CO; Themeles E; Yusuf S
Circulation; 2013 Jul; 128(3):237-43. PubMed ID: 23770747
[TBL] [Abstract][Full Text] [Related]
18. Neurosurgical complications of direct thrombin inhibitors--catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran.
Garber ST; Sivakumar W; Schmidt RH
J Neurosurg; 2012 May; 116(5):1093-6. PubMed ID: 22394293
[TBL] [Abstract][Full Text] [Related]
19. Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
Ali A; Bailey C; Abdelhafiz AH
Age Ageing; 2012 Sep; 41(5):681-4. PubMed ID: 22378612
[TBL] [Abstract][Full Text] [Related]
20. [Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].
Bachellerie B; Ruiz S; Conil JM; Crognier L; Seguin T; Georges B; Fourcade O
Ann Fr Anesth Reanim; 2014 Jan; 33(1):44-6. PubMed ID: 24378048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]